A Phase 3 randomized, open-label trial of selinexor, pomalidomide, and dexamethasone versus elotuzumab, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
multiple myeloma,pomalidomide,elotuzumab,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要